GSK makes £25 million investment in future of Montrose plant
ByGraham Brown
Inside the GlaxoSmithKline plant at Montrose.
Pharmaceutical giant GlaxoSmithKline has delivered a £25 million vote of confidence in its Angus operation.
GSK president of global manufacturing and supply Roger Connor made the major investment announcement at the firm’s Montrose plant this morning.
GSK is investing in new state of the art facilities and equipment to bring production of the ingredients for four new pharmaceutical products to Montrose.
The investment will create 25 new jobs, bringing the firm’s Scottish workforce up to 750.
Mr Connor said: “Our teams in Montrose and Irvine are world class and have worked hard to bring new facilities to the two sites.”
Finance secretary John Swinney was at Montrose this morning and said: “GSK’s investment is testament to the skill of the Scottish workforce and illustrates the confidence international companies have in Scotland as a country to invest in.
“Montrose has the infrasructure, experience and skills to deliver success for GSK and the company’s commitment to Scotland is further positive news for financial enterprise and the wider Scottish ecomnomy.”
